These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 32948004)
1. Optimization of Light Intensity, Temperature, and Nutrients to Enhance the Bioactive Content of Hyperforin and Rutin in St. John's Wort. Kuo CH; Chou YC; Liao KC; Shieh CJ; Deng TS Molecules; 2020 Sep; 25(18):. PubMed ID: 32948004 [TBL] [Abstract][Full Text] [Related]
2. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content. Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of total hypericin and hyperforin in St. John's wort extracts by HPLC with electrochemical detection. Rückert U; Likussar W; Michelitsch A Phytochem Anal; 2007; 18(3):204-8. PubMed ID: 17500362 [TBL] [Abstract][Full Text] [Related]
4. Comparison of German St. John's wort products according to hyperforin and total hypericin content. Wurglics M; Westerhoff K; Kaunzinger A; Wilke A; Baumeister A; Dressman J; Schubert-Zsilavecz M J Am Pharm Assoc (Wash); 2001; 41(4):560-6. PubMed ID: 11486982 [TBL] [Abstract][Full Text] [Related]
5. Effects of UV-B on secondary metabolites of St. John's Wort (Hypericum perforatum L.) grown in controlled environments. Brechner ML; Albright LD; Weston LA Photochem Photobiol; 2011; 87(3):680-4. PubMed ID: 21275996 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the synaptosomal uptake inhibition of serotonin by St John's wort products. Schulte-Löbbert S; Holoubek G; Müller WE; Schubert-Zsilavecz M; Wurglics M J Pharm Pharmacol; 2004 Jun; 56(6):813-8. PubMed ID: 15231048 [TBL] [Abstract][Full Text] [Related]
7. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line. Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377 [TBL] [Abstract][Full Text] [Related]
8. Effect of eluent pH on the HPLC-UV analysis of hyperforin from St. John's Wort (Hypericum perforatum L.). Fourneron JD; Naït-Si Y Phytochem Anal; 2006; 17(2):71-7. PubMed ID: 16634282 [TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of St. John's wort from different Italian regions. Pietta P; Gardana C; Pietta A Farmaco; 2001; 56(5-7):491-6. PubMed ID: 11482784 [TBL] [Abstract][Full Text] [Related]
10. Topical application of St John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells. Schempp CM; Winghofer B; Lüdtke R; Simon-Haarhaus B; Schöpf E; Simon JC Br J Dermatol; 2000 May; 142(5):979-84. PubMed ID: 10809859 [TBL] [Abstract][Full Text] [Related]
11. An in vitro and hydroponic growing system for hypericin, pseudohypericin, and hyperforin production of St. John's wort (Hypericum perforatum CV new stem). Murch SJ; Rupasinghe HP; Saxena PK Planta Med; 2002 Dec; 68(12):1108-12. PubMed ID: 12494339 [TBL] [Abstract][Full Text] [Related]
12. St. John's wort (Hypericum perforatum) and breastfeeding: plasma and breast milk concentrations of hyperforin for 5 mothers and 2 infants. Klier CM; Schmid-Siegel B; Schäfer MR; Lenz G; Saria A; Lee A; Zernig G J Clin Psychiatry; 2006 Feb; 67(2):305-9. PubMed ID: 16566628 [TBL] [Abstract][Full Text] [Related]
13. St John's wort: Prozac from the plant kingdom. Di Carlo G; Borrelli F; Ernst E; Izzo AA Trends Pharmacol Sci; 2001 Jun; 22(6):292-7. PubMed ID: 11395157 [TBL] [Abstract][Full Text] [Related]
14. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis. Ng QX; Venkatanarayanan N; Ho CY J Affect Disord; 2017 Mar; 210():211-221. PubMed ID: 28064110 [TBL] [Abstract][Full Text] [Related]